S. Nakano et al., MITOCHONDRIAL-DNA POINT MUTATION AT NUCLEOTIDE-PAIR-3316 IN A JAPANESE FAMILY WITH HETEROGENEOUS PHENOTYPES OF DIABETES, Endocrine journal, 45(5), 1998, pp. 625-630
A mitochondrial DNA (mtDNA) paint mutation at nucleotide pair (np) 331
6 has been reported in relation to diabetes. We recently encountered a
non-obese family with this type of mutation. The proband in the affec
ted family, a 49-year-old woman who had been previously diagnosed as h
aving an insulin-requiring non-insulin-dependent diabetes mellitus (NI
DDM), was referred to our hospital for treatment of diabetic gangrene
in her left foot. Her insulin secretary capacity was markedly reduced,
but the insulin sensitivity evaluated by the euglycemic hyperinsuline
mic clamp technique was normal. In addition, her serum lactate level w
as markedly increased after a 5 min ambulation, although her serum pyr
uvate and ketones remained within the normal range. Twenty-year-old tw
in sons had been treated with insulin since the age of 7, when both we
re diagnosed with insulin-dependent diabetes mellitus (IDDM). The prob
and's mother, a 68-year-old, was nondiabetic at this time. MtDNA analy
sis revealed a point mutation at np 3316 in all family members, which
was homoplasmic for the mutation on a photograph of agarose gel electr
ophoresis containing ethidium bromide under ultraviolet light. This mu
tation seemed to be maternally transmitted in the family, and the onse
t of diabetes was occurring earlier and the insulin secretory capacity
was declining from generation to generation, so that these findings s
uggest that the point mutation at np 3316 is associated with various p
henotypes of diabetes.